Akerna Shares Dip 53%, Here’s 78 Biggest Movers From Yesterday
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.
This Healthcare Stock Jumps Around 188%, Here’s 83 Biggest Movers From Yesterday
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
12 Consumer Discretionary Stocks Moving In Monday’s After-Market Session
Gainers
Tuesday Morning (NASDAQ:TUEM) shares moved upwards by 12.8% to $0.4 during Monday's after-market session. The market value of their outstanding shares is at $33.9 million.
Why Is NeuroSense Therapeutics Surging by 70%? 46 Stocks Moving In Monday’s Mid-Day Session
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.
EXCLUSIVE: Creatd To Raise Up To $40M Via Rights Offering At Premium To Fund Its Expansion Plans
Creatd Inc's (NASDAQ: CRTD) board approved a rights offering of up to $40 million for 20 million shares at $2 per unit. The offer price implies a premium of 147.5% to Creatd's May 25 closing price of $0.808.
Earnings Scheduled For May 16, 2022
Companies Reporting Before The Bell
• AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
